找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cardiovascular Risk Assessment in Primary Prevention; Michael D. Shapiro Book 2022 The Editor(s) (if applicable) and The Author(s), under

[复制链接]
查看: 12763|回复: 55
发表于 2025-3-21 18:59:08 | 显示全部楼层 |阅读模式
书目名称Cardiovascular Risk Assessment in Primary Prevention
编辑Michael D. Shapiro
视频video
概述Offers a comprehensive overview of risk assessment in primary prevention of cardiovascular disease.Empowers readers to perform state-of-the-art risk assessment to prevent cardiovascular disease.Discus
丛书名称Contemporary Cardiology
图书封面Titlebook: Cardiovascular Risk Assessment in Primary Prevention;  Michael D. Shapiro Book 2022 The Editor(s) (if applicable) and The Author(s), under
描述This book is the first comprehensive text dedicated to risk assessment in the primary prevention of atherosclerotic cardiovascular disease. It provides an overview of current evidence regarding approaches to risk assessment, traditional and emerging risk factors, and atherosclerosis imaging for refinement of risk estimation. The volume seeks to provide an essential resource for professionals in the field to assess their patients for risk of cardiovascular disease. .The book is divided into five sections, starting off with an overview of current best practices to risk assessment in primary prevention around the world. The second section discusses traditional risk factors, such as hypercholesterolemia, hypertension, diabetes, smoking, and obesity. The third section reviews the newly introduced concept of ‘Risk Enhancers’. The fourth section offers insight on novel risk factors, with in-depth discussion regarding lipoprotein(a), high-sensitivity CRP, apolipoproteinB, social determinants of health, stress and cardiovascular disease. and polygenic risk scores. The final section covers the use of non-invasive atherosclerosis imaging (computed tomography and ultrasound-based techniques) a
出版日期Book 2022
关键词Risk Assessment of Atherosclerotic Cardiovascular Disease; Primary Prevention of Atherosclerotic Card
版次1
doihttps://doi.org/10.1007/978-3-030-98824-1
isbn_softcover978-3-030-98826-5
isbn_ebook978-3-030-98824-1Series ISSN 2196-8969 Series E-ISSN 2196-8977
issn_series 2196-8969
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

书目名称Cardiovascular Risk Assessment in Primary Prevention影响因子(影响力)




书目名称Cardiovascular Risk Assessment in Primary Prevention影响因子(影响力)学科排名




书目名称Cardiovascular Risk Assessment in Primary Prevention网络公开度




书目名称Cardiovascular Risk Assessment in Primary Prevention网络公开度学科排名




书目名称Cardiovascular Risk Assessment in Primary Prevention被引频次




书目名称Cardiovascular Risk Assessment in Primary Prevention被引频次学科排名




书目名称Cardiovascular Risk Assessment in Primary Prevention年度引用




书目名称Cardiovascular Risk Assessment in Primary Prevention年度引用学科排名




书目名称Cardiovascular Risk Assessment in Primary Prevention读者反馈




书目名称Cardiovascular Risk Assessment in Primary Prevention读者反馈学科排名




单选投票, 共有 1 人参与投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 21:10:59 | 显示全部楼层
Arbitrary Precision Floating-Pointchronic inflammatory conditions [e.g., lupus, rheumatoid arthritis, human immunodeficiency virus (HIV)]. As a result, there is growing focus on the identification of novel risk-enhancing conditions and use of biomarkers and cardiovascular imaging to further improve risk stratification and risk recla
发表于 2025-3-22 03:51:09 | 显示全部楼层
Undergraduate Texts in Mathematicsimproving cardiovascular risk assessment by studying larger and more diverse epidemiological cohorts, leveraging the power of precision medicine, and incorporating measures of social determinants of health into risk prediction algorithms.
发表于 2025-3-22 06:04:45 | 显示全部楼层
发表于 2025-3-22 10:42:48 | 显示全部楼层
发表于 2025-3-22 13:12:42 | 显示全部楼层
Deborah Trevallion,Maura Sellarsre ASCVD can be used for both individual and population risk stratification and should be collected systematically. In this chapter, we begin with a basic overview of the epidemiology and pathophysiology of familial cardiovascular risk. We then outline the clinical recommendations for collecting a f
发表于 2025-3-22 21:03:24 | 显示全部楼层
发表于 2025-3-23 00:34:48 | 显示全部楼层
Using Other Languages on the Java Platform,essure reduction, renin–angiotensin–aldosterone system (RAAS) inhibition, glycemic control with metformin and sodium–glucose cotransporter-2 inhibitors, lipid control with statins and ezetimibe, and possibly aspirin are the mainstay therapies for CVD risk reduction in CKD patients. Lifestyle interve
发表于 2025-3-23 04:59:43 | 显示全部楼层
发表于 2025-3-23 06:48:48 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-3 15:41
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表